1. Benitz K-F, Roberts G, Yusa A. Morphologic effects of minocycline in laboratory animals. Toxicol Appl Pharmacol 1967;11:150–170.
2. Attwood HDH. A black thyroid and minocycline treatment. Br Med J 1976;2:1109–1110.
3. Hecht DA, Wenig BM, Sessions RB. Black thyroid: a collaborative series. Otolaryngol Head Neck Surg 1999;121:293–296.
4. Tsokos M, Schröder S. Black thyroid. Int J Legal Med 2006;120:157–159.
5. Hall AH, Bean SM. Minocycline-induced black thyroid. Diagn Cytopathol 2010;38:579–580.
6. Azuma N, Hashimoto N, Nishioka A, et al. Black thyroid. Intern Med 2010;49:1835–1836.
7. Gordon G, Sparano BM, Kramer AW, et al. Thyroid gland pigmentation and minocycline therapy. Am J Pathol 1984; 117:98–109.
8. Saul SH, Dekker A, Lee R, et al. The black thyroid. Its relation to minocycline use in man. Arch Pathol Lab Med 1983;107:173–177.
9. Miller BT, Lewis C, Bentz BG. Black thyroid resulting from short-term doxycycline use: case report, review of the literature, and discussion of implications. Head Neck 2006;28:373–377.
10. LaPorta VN, Nikitakis NG, Sindler AJ, et al. Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review. J Clin Periodontol 2005;32:119–122.
11. Reed DN, Gregg FO, Corpe RS. Minocycline-induced black bone disease encountered during total knee arthroplasty. Orthopedics 2012;35:e737–e739.
12. Tsunekawa T, Jones KW, Doty JR. Black pigmented aortic valve and sinus of Valsalva caused by life-long minocycline therapy. Interact Cardiovasc Thorac Surg 2014;19:339–340.
13. Bowen AR, McCalmont TH. The histopathology of subcutaneous minocycline pigmentation. J Am Acad Dermatol 2007;57:836–839.
14. Taurog A, Dorris ML, Doerge DR. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. thyroid. Thyroid 1996;6:211–219.
15. Reid JD. The black thyroid associated with minocycline therapy. A local manifestation of a drug-induced lysosome/substrate disorder. Am J Clin Pathol 1983;79:738–746.
16. Enochs WS, Nilges M, Swartz H. The minocycline-induced thyroid pigment and several synthetic models: identification and characterization by electron paramagnetic resonance spectroscopy. J Pharmacol Exp Ther 1993;266:1164–1176.
17. Bell CD, Kovacs K, Horvath E, et al. Histologic, immunohistochemical, and ultrastructural findings in a case of minocycline-associated “black thyroid.” Endocr Pathol 2001;12:443–451.
18. Riley PA. Melanin. Int J Biochem Cell Biol 1997;29:1235–1239.
19. Kandil E, Abdel Khalek M, Alabbas H, et al. Black thyroid associated with thyroid carcinoma. Int J Endocrinol 2010;2010;1–3.
20. Onyia JN, Forrest LA, Forsthoefel K. Papillary carcinoma associated with black thyroid gland. Am J Otolaryngol 1996;17:299–302.
21. Sharma V, Cui H, Whalen G, et al. A case of trabecular adenoma of the thyroid with black pigmentation. Thyroid 2007;17:593–594.
22. Withrow SJ, Vail DM, Page RL. Tumors of the endocrine system. In: Withrow and MacEwen's small animal clinical oncology. 5th ed. St Louis: Elsevier Inc, 2013;514–515.
Advertisement
Dr. Ackermann's present address is Oregon Veterinary Diagnostic Laboratory, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331.